Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity. Ginsberg D, Gousse A, Keppenne V, Sievert K-D, Thompson C, Lam W, Brin MF, Jenkins B, Haag-Molkenteller C J Urol. 2012 Apr 12. PMID: 22503020. Abstract CommentRecommendBookmarkWatch